|
Accelerating R&D for Snakebites: Building a Common Agenda for Progress
Tuesday 19 September 2023, 09:00am - 04:30pm
Location : Médecins Sans Frontières (MSF) Audience : If you wish to receive an invitation to this event please contact us Categories : Conference, GHF event |
The Geneva Health Forum, the University of Geneva, Médecins Sans Frontières and Policy Cures Research, with support from Wellcome, are delighted to invite you to our upcoming event on International Snakebite Awareness Day.
Accelerating R&D for Snakebites:
Building a Common Agenda for Progress
Tuesday 19th September
9:00am to 4:30pm
MSF Building, route de Ferney 140, 1202 Geneva , Switzerland
 |
 |
 |
 |
 |
There has been a concerted effort over the recent years to raise the profile of snakebite envenoming (SBE) and stimulate investment in R&D for this burden. SBE has been one of the only WHO NTDs to see significant increases in its R&D funding, with many other diseases experiencing a decline or plateau in recent years. Despite this positive trend, there is concern around the sustainability of funding and translating research into impact due to the lack of long-term funding commitments.
Now is the time to build on recent achievements and for the SBE community to examine structural weaknesses in the R&D ecosystem, with learnings from the wider NTD community, to accelerate progress for SBE R&D. There is an urgent need to diversify SBE funders, build clear consensus on R&D priorities, and highlight the return on investment of SBE R&D.
This event will gather SBE actors, as well as traditional NTD stakeholders, to define the future direction of the SBE R&D ecosystem and apply learnings from other NTD experiences. Building on Policy Cures Research’s SBE medicines landscape report and database, we will discuss a common approach to shape decision-making and ensure that SBE continues on its upward trajectory.
Below is the agenda for the session:
Welcome and introduction
---
Keynote address
---
Session 1: How is the SBE R&D ecosystem hindering progress?
---
Session 2: How do we leverage the One Health agenda to elevate Snakebite Envenoming research?
---
Lunch
---
Session 3: How do we clarify the priorities for Snakebite Envenoming Research and Development?
---
Session 4: What is the business case for investing in Snakebite Envenoming?
---
Next steps & closing remarks
We hope you’ll join us for this important event, please RSVP by 21 July 2023.
Location : Médecins Sans Frontières (MSF) |